GPX4 and cardiomyopathy: Doxorubicin-induced cardiomyopathy correlated with decreased expression of GPx4 and increased lipid peroxidation, leading to ferroptosis and functional impairment of the left ventricular ejection fraction with increased cardiac fibrosis [122].